Form 4: Celanese Director Acquires Phantom Stock

Sentiment:

Insider Transaction Report


Celanese Corporation director Kathryn Hill acquired 1.86 shares of phantom stock as dividend equivalents, increasing her beneficial ownership to 2,946.61 shares.

Summary

  • Director Kathryn Hill acquired 1.86 shares of phantom stock.
  • This acquisition represents dividend equivalents on compensation deferred under Celanese Corporation's 2008 Deferred Compensation Plan.
  • Each phantom stock share represents the right to receive one share of Celanese Common Stock.
  • The phantom stock becomes payable in Common Stock shares upon the termination of Ms. Hill's service as a director.
  • Following this transaction, Ms. Hill beneficially owns 2,946.61 shares of phantom stock.
  • The underlying Common Stock was valued at $47.42 per share for the dividend equivalent calculation.

Sentiment

Score: 6

Explanation: The filing reports a routine, non-discretionary acquisition of phantom stock by a director as part of a deferred compensation plan. This is a neutral event for the company's operational performance but slightly positive for insider alignment, as it increases the director's stake through a compensation mechanism.

Positives

  • Director Kathryn Hill's beneficial ownership of phantom stock increased, indicating continued participation in the company's deferred compensation plan.
  • The acquisition of phantom stock through dividend equivalents is a routine part of the company's compensation structure for directors, aligning their interests with shareholders.

Negatives

  • No negative aspects are explicitly stated or implied by this routine insider transaction filing.

Risks

  • No specific risks related to the company's operations or financial health are disclosed in this Form 4 filing.

Future Outlook

The phantom stock acquired will become payable in shares of Common Stock following the termination of the reporting person's service as a director of the Company, as provided in the 2008 Deferred Compensation Plan.

Management Comments

  • No direct management comments or quotes are provided in this Form 4 filing, which is a standard disclosure of insider transactions.

Industry Context

This filing represents a routine insider transaction related to director compensation, which is a common practice across publicly traded companies to align director interests with shareholders through equity-based incentives. It does not reflect broader industry trends or competitive dynamics.

Comparison to Industry Standards

  • The acquisition of phantom stock as dividend equivalents under a deferred compensation plan is a standard practice for director compensation in many large public corporations.
  • While specific comparable companies or projects are not detailed in this filing, such plans are common across industries, including the chemicals sector where Celanese operates, to retain and incentivize board members.
  • The value of the dividend equivalent is tied to the company's common stock performance, a typical alignment mechanism.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compensation Plan DetailThe filing references the Company's 2008 Deferred Compensation Plan, under which dividend equivalents are accrued as phantom stock. This plan dictates the terms of deferred compensation for directors.N/AReinforces the existing compensation structure for directors, aligning their long-term interests with shareholder value through equity-based incentives.

Related Party Transactions

  • The acquisition of phantom stock by a director (Kathryn Hill) from Celanese Corporation as part of a compensation plan constitutes a related party transaction.

Stakeholder Impact

  • Shareholders: Minimal direct impact. This is a routine compensation event and does not dilute existing shares or significantly alter the company's financial position. It aligns director interests with shareholders.
  • Employees: No direct impact mentioned.
  • Customers/Suppliers/Creditors: No direct impact mentioned.

Next Steps

  • The phantom stock will become payable in Common Stock shares upon the termination of Kathryn Hill's service as a director.

Key Dates

DateDescription
08/11/2025Date of transaction for phantom stock acquisition.
08/13/2025Date the Form 4 was signed and filed.

Keywords

Celanese Corp, CE, SEC Form 4, insider transaction, phantom stock, dividend equivalents, director compensation, deferred compensation, Kathryn Hill

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.